Evidence map›Paper›PMID 33529722›Full record

ArticleThe journal of allergy and clinical immunology. In practice2021

The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World.

Matthew Greenhawt, Elissa M Abrams, John Oppenheimer, Timothy K Vander Leek, Douglas P Mack, Alexander G Singer, Marcus Shaker

Open access · bronzeAbstract readEditorialComment
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. The adverse reactions to vaccines practice parameter 10 years on-what have we learned?Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Guideline
  2. Review
  3. Article
  4. Anaphylaxis: Definition and criteria.Journal of food allergy · 2024
    Article
  5. PEG allergy - A COVID-19 pandemic-made problem? A German perspective.The World Allergy Organization journal · 2022
    Article
  6. Article
  7. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Article
  8. Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Reply to "How important is the second dose of the COVID-19 mRNA vaccine?"The journal of allergy and clinical immunology. In practice · 2021
    Article
  15. How important is the second dose of the COVID-19 mRNA vaccine?The journal of allergy and clinical immunology. In practice · 2021
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Matthew GreenhawtDepartment of Pediatrics, Section of Allergy and Immunology, Children's Hospital Colorado, University of Colorado Denver School of Medicine, Denver, Colo. Electronic address: Matthew.Greenhawt@childrenscolorado.org.
Elissa M AbramsDepartment of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, MB, Canada.
John OppenheimerRutgers New Jersey Medical School, Newark, NJ.
Timothy K Vander LeekPediatric Allergy and Asthma, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
Douglas P MackMcMaster University, Hamilton, ON, Canada; Halton Pediatric Allergy, Burlington, ON, Canada.
Alexander G SingerDepartment of Family Medicine, University of Manitoba, Winnipeg, MB, Canada.
Marcus ShakerDartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon, NH; Geisel School of Medicine at Dartmouth, Hanover, NH.
University of Manitoba · CADartmouth College · USMcMaster University · CARutgers, The State University of New Jersey · USUniversity of Alberta · CAUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnaphylaxisCOVID-19VaccinesHumansMedical OverusePandemicsRNA, MessengerSARS-CoV-2RNA, MessengerVaccinesAdverse effectsAnaphylaxisCOVID-19Graded challengeParameterShared decision-makingVaccine

Identifiers

PMID33529722
PMCPMC7847187
OpenAlexW3126795547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.